on (#5G2SP)
Biolyse’s unconventional move to try to produce single-dose COVID-19 vaccines adds to a fierce global debate about who controls vaccine knowledge and production in a pandemic.
| Link | https://www.pri.org/programs/the-world |
| Feed | http://www.pri.org/feed/index.1.rss |
| Updated | 2026-07-06 22:00 |